Hyperfine's Portable MRI Shows 98% Diagnostic Concordance in Neurology Clinics

Event summary

  • Hyperfine's NEURO PMR study showed 98% diagnostic concordance between its portable Swoop® MRI and conventional high-field MRI in neurology clinics.
  • 125 patients with conditions like headache, dementia, and multiple sclerosis were imaged using both systems across two clinical sites.
  • Patients preferred portable MRI by a factor of four, citing superior comfort, lower anxiety, and better overall satisfaction.
  • The Swoop® system was operated successfully by trained clinical staff without the need for specialized MR technologists.
  • Results were presented by Dr. Laszlo Mechtler at the ASN Annual Meeting on January 16, 2026.

The big picture

Hyperfine's study results position its portable MRI as a disruptive force in neurology diagnostics, addressing long-standing barriers to on-site imaging. The technology aligns with broader trends toward decentralized healthcare delivery and patient-centric care models. If adoption scales as suggested by the study, it could reshape the $6B+ U.S. MRI market by enabling more efficient, accessible brain imaging outside traditional hospital settings.

What we're watching

Adoption Dynamics
How quickly neurology clinics will integrate portable MRI into routine practice, given its demonstrated diagnostic utility and operational simplicity.
Reimbursement Stability
Whether existing CPT codes will continue to support reimbursement for portable MRI scans, ensuring financial viability for clinics.
Competitive Response
The pace at which traditional MRI manufacturers may develop portable alternatives to challenge Hyperfine's first-mover advantage.